Top compounds associated with response to CDA


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.18 6e-07
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.17 1e-06
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 4e-06
mRNA vincristine CTRPv2 pan-cancer AAC -0.14 1e-05
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.14 1e-05
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.12 2e-05
mRNA YM201636 GDSC1000 pan-cancer AAC -0.14 3e-05
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.14 3e-05
Download CSV